Advertisement
Asia
Subscribe to Asia

The Lead

China FDA exempts ‘equivalent’ devices from clinical trials

June 18, 2015 12:40 pm | by Elizabeth Orr, FDA | News | Comments

Devicemakers won’t have to stage new clinical trials of their devices to gain approval in China if they can demonstrate that they’re basically equivalent to devices already on the market, Chinese regulators say.

Fibromyalgia Treatment Market Slowing

May 13, 2015 11:08 am | by GlobalData | News | Comments

The treatment market value for fibromyalgia across the seven major markets will reach $1.9...

Afghan Poppy Farmers Say New Seeds Will Boost Opium Output

May 5, 2015 11:24 am | by Mirwais Khan and Lynne O'Donnell, Associated Press | News | Comments

This year, many Afghan poppy farmers are expecting a windfall as they get ready to harvest opium...

Prostate Cancer Treatment Market To Grow To $8.2 Billion

April 30, 2015 11:46 am | News | Comments

The global treatment market value for prostate cancer will expand more than threefold by 2023....

View Sample

FREE Email Newsletter

Cancer Surge in China Prompts Rise of Special Patient Hotels

April 13, 2015 1:29 pm | by Jack Chang, Associated Press | News | Comments

Many so-called cancer hotels dot the neighborhoods around Chinese hospitals, giving patients an affordable, cozy place to wait for appointments and undergo outpatient treatment.

Merck, Asian and African Universities Collaborate on Diabetes

April 13, 2015 12:49 pm | by Merck | News | Comments

Merck is introducing Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.

Microbix Signs Virology Distribution Agreement for South Korea

April 6, 2015 12:23 pm | News | Comments

Microbix Biosystems has signed an exclusive distribution agreement with Kim & Friends, Inc. The agreement provides Microbix with improved access to the key South Korean market for its virology products.

Advertisement

Asia Agencies Purchase U.S. Simulation Software

April 6, 2015 12:01 pm | by Simulations Plus | News | Comments

Simulations Plus announced that several regulatory agencies around the world have added licenses of software for pharmaceutical discovery and development within the past three months.

Pfizer Stops China Vaccine Sales as Import License Expires

April 2, 2015 1:45 pm | by The Associated Press | News | Comments

Pfizer has stopped selling its Prevnar 7 pneumonia vaccine in China after its import license expired, but the U.S. drugmaker still intends to launch the world's most widely used vaccine, Prevnar 13, in that market.

ImmunoGen Lands Licensing Deal with Takeda

March 23, 2015 4:08 pm | by The Associated Press | News | Comments

Takeda will use ImmunoGen's technology to develop cancer treatments. ImmunoGen will get $20 million upfront and is eligible for milestone payments potentially totaling up to $210 million, plus royalties on sales.

Report: Japan's Pharmaceutical Market to See 'Tepid' Growth

March 2, 2015 8:10 am | by Andy Szal, Digital Reporter | News | Comments

A recent report from research firm GlobalData predicted Japan will see a "tepid" recovery in its pharmaceutical market over the next several years. The London-based firm estimates Japan’s pharmaceutical market will climb from $72.8 billion in 2013 to $79.8 billion by 2020, a Compound Annual Growth Rate of 1.3 percent.

Takeda Expands Pharma Operations in Singapore

February 25, 2015 8:14 am | News | Comments

Takeda Pharmaceutical Co., Japan's largest drug company, has expanded its Singapore operations by relocating its emerging markets business unit to the city-state from Zurich, executives said at an inauguration ceremony Wednesday.

Advertisement

Report: Vitamin Supplement Market Expected to Increase by 60 Percent by 2020

February 24, 2015 3:19 pm | by Andrew Szal, Editor, Pharmaceutical Processing | News | Comments

The analysis by New York-based Persistence Market Research predicted Vitamin D supplements would lead the growth in the industry over that span. The report expects increasing geriatric populations, particularly in Asia, to bolster demand for Vitamin D.

Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi and Harvoni in India

February 23, 2015 8:13 am | News | Comments

Mylan announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi and Harvoni for the treatment of chronic hepatitis C, in India.

Indian Health Authorities Say 700 Have Died in Flu Outbreak

February 20, 2015 8:36 am | News | Comments

Health authorities were working to ensure remote hospitals in northern and western India had adequate medical supplies for a flu outbreak that has claimed more than 700 lives in 10 weeks.

China’s Colorectal Cancer Treatment Market Value to Exceed $1 Billion by 2023, says GlobalData

February 18, 2015 8:57 am | News | Comments

The Chinese treatment market for colorectal cancer (CRC) will expand almost fourfold in value from an estimated $259 million in 2013 to $1.05 billion by 2023, at an impressive Compound Annual Growth Rate (CAGR) of 15.1%, according to research and consulting firm GlobalData.

Merck Takes Full Promotional Responsibility for Erbitux in Japan

February 13, 2015 8:43 am | News | Comments

Merck has announced that the company and Bristol-Myers Squibb have agreed to transfer full responsibility for the promotion of Erbitux® (cetuximab) to Merck in Japan as of May 1, 2015

Advertisement

U.S. Challenges Chinese Export Program

February 11, 2015 11:56 am | by Andrew Szal, Editor, Pharmaceutical Processing | News | Comments

The United States has accused the Chinese government of providing prohibited subsidies on a wide range of the country's exports, providing an unfair advantage in the marketplace and hindering American businesses.

Report: Single-Use Bioreactors Market to Grow to $471M by 2019

January 28, 2015 8:02 am | News | Comments

The single use bioreactors (SUBs) market is expected to grow at a double digit CAGR of 18.4% to reach $470.9 million by 2019 from $202.5 million in 2014. Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations.

EMA Recommends Suspending GVK Biosciences Medicines over Flawed Studies

January 23, 2015 8:06 am | News | Comments

A number of medicines for which authorization in the European Union (EU) was primarily based on clinical studies conducted at GVK Biosciences in Hyderabad, India should be suspended, says the European Medicines Agency (EMA).     

Catalent Biologics and MGC Pharma Announce Partnership for Biomanufacturing in Asia

January 19, 2015 12:29 pm | News | Comments

Catalent Pharma Solutions and Mitsubishi Gas Chemical Company, Inc. (MGC), have entered into a partnership agreement to co-promote Catalent’s proprietary GPEx® technology in the Asian market.          

Roche, Meiji and Fedora to Collaborate on New Antibiotic to Fight Increasing Bacterial Resistance

January 13, 2015 11:26 am | News | Comments

Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the development and commercialization of OP0595, a beta-lactamase inhibitor in phase I clinical development. Under the agreement, Roche obtains worldwide rights from both companies for development and commercialization with the exception of Japan, where Meiji will retain sole commercialization rights.

Health Canada Quarantines Products From Two Indian Companies

December 24, 2014 11:00 am | News | Comments

This action comes in light of recent information from a trusted regulatory partner that raises concerns about the reliability of the laboratory data generated at these sites. Health Canada is taking this action as an interim precautionary measure to help mitigate any potential risk.

PPD and SNBL to Provide Clinical Development Services in Japan

December 24, 2014 8:25 am | News | Comments

Pharmaceutical Product Development and Shin Nippon Biomedical Labs have formed a joint venture that will provide a full range of clinical development services in Japan, including Phase I-IV clinical trial monitoring, project management, site intelligence and activation, biostatistics, data management, medical writing, pharmacovigilance, regulatory and FSP services.

Sartorius Selling Industrial Technologies Division to Minebea Co.

December 22, 2014 8:36 am | News | Comments

Sartorius, an international laboratory and pharmaceutical equipment provider, is selling its Industrial Technologies Division (Intec) to the Japanese Minebea Co., Ltd. (Minebea) and their partner, the Development Bank of Japan Inc.   

Charges Dropped Against Two Former Lilly Scientists

December 8, 2014 8:34 am | News | Comments

Two former Eli Lilly and Co. employees who were accused of sending trade secrets worth more than $55 million to a competing Chinese drug company will no longer face charges, the U.S. attorney's office announced Friday.      

GlobalData: Age-Related Macular Degeneration Treatment Market Value to Exceed $10B by 2023

December 4, 2014 9:51 am | News | Comments

The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and Japan) will almost double in value from $5.1 billion in 2013 to $10.1 billion by 2023, according to research and consulting firm GlobalData.

Otsuka to Buy Avanir for $3.5B

December 2, 2014 7:08 am | by By The Associated Press | News | Comments

Otsuka Pharmaceutical will spend $3.5 billion in cash to buy Avanir Pharmaceuticals in a deal that expands the Japanese drugmaker's portfolio of neurologic disease treatments. Avanir shareholders will receive $17 per share, according to the agreement announced Tuesday.

Vetter Opens Singapore Office to Support Growing Asian Healthcare Market

November 20, 2014 8:42 am | News | Comments

Vetter has announced the opening of a new representative office in Singapore. The announcement was made at a ceremony attended by members of local government agencies and a number of executives of pharmaceutical/biotech companies with a presence in the Asian region, as well as Vetter executives.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading